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a b s t r a c t
Even if this is not its primary mission, with the rapid progress in
techniques in the ﬁelds of prenatal diagnosis and neonatal resus-
citation over the last 3decades, perinatal medicine now plays an
active role in the social treatment of disability. This activity was
developed independently of new conceptions of disability which,
through the impetus provided by disabled personsmovements and
disability studies, were at the same time the object of a broad inter-
national debate which led to classiﬁcation and to new legislation
and recommendations. This situation of impermeability between
the two ﬁelds of intervention on disability –perinatal medicine on
the one hand, public policies and social action on the other – led
to practices being anchored in radically different conceptions of
disability. The author sets out the current situation for the man-
agement and practice of prenatal diagnosis in France, and attempts
to analyse the reasons behind difﬁculties in reconciling these two
ﬁelds of intervention by looking back at the sociohistorical modal-
ities of their construction. Two ideas are put forward: the State’s
delegation to different actors in the two ﬁelds, and the extension –
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ratiﬁed by the enclave of the medical institution– of “therapeutic
abortion” to include foetal indications.









r é s u m é
Avec l’avancée rapidedes techniquesdans ledomainedudiagnostic
prénatal et de la réanimation néonatale au cours des trois dernières
décennies, la médecine périnatale en est venue à participer active-
ment,mêmesi cen’estpas samissionpremière, au traitement social
du handicap. Cette activité s’est élaborée totalement en marge
des nouvelles conceptions du handicap qui, sous l’impulsion des
mouvements de personnes handicapées et des disability studies,
ont fait l’objet durant la même période, d’un large débat inter-
national concrétisé par un travail de classiﬁcation et de nouvelles
législations et recommandations. Cette situation d’étanchéité entre
deux champs d’intervention du handicap : la médecine périnatale,
d’un côté, les politiques publiques et l’action sociale de l’autre,
conduit à un ancrage des pratiques dans des conceptions du hand-
icap radicalement différentes. L’auteur dresse un état des lieux de
l’encadrement et des pratiques du diagnostic prénatal en France,
puis tente d’analyser les raisons de la difﬁcile conciliation entre ces
deux champs d’intervention en revenant sur les modalités socio-
historiques de leur construction. Deux pistes sont évoquées : la
délégation par l’État à des acteurs différents dans les deux champs
et l’élargissement de l’« avortement thérapeutique » aux indications
fœtales entériné dans l’enclave de l’institution médicale.
© 2010 Association ALTER. Publié par Elsevier Masson SAS. Tous
droits réservés.
Technological evolutions, in the ﬁelds of prenatal diagnosis (PND) and neonatal resuscitation, lead
one to see perinatality practices as a new area of intervention on disability, a new mode of social
treatment of impairments, which can in some way be added to the disability policies and treatment
procedures which were developed throughout the 20th century.
But whilst public policies and social action on the one hand, and perinatal medicine1 on the other,
contribute in their own ways towards the social treatment of disability, it would seem that they do
so independently, each ﬁeld being governed by different logics. It would appear to be difﬁcult to
reconcile the two modes of management, which result, with the promotion of the social participation
of disabled persons, afﬁrmative actions and antidiscriminatory legislation on the one hand, and the
selection of births as a means of disability “prevention” on the other. In the ﬁrst section, I will set out
the current situation for PND and management in France and I will provide some comparative data for
other European countries. I will then brieﬂy summarise what social sciences are telling us about these
practices. Finally, I will suggest avenues of thought to try to understand the complex conciliation of
these two ﬁelds, partly inherent in the historical modes of their constitution.
1. Regulations and practices in prenatal diagnosis in France
In France, PND is deﬁned by the French public health code as all “medical practices the purpose of
which is to detect, in utero, in the embryoor foetus, any ailment of particular gravity”.With the initially
1 Perinatal medicine deals with the monitoring of pregnancies and births and the care of mother and child during the ﬁrst
days of the child’s life.
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limited use of providing genetic advice to couples who might pass on an illness to their children, over
the last 30years, it has gradually becomemore generalised, ﬁrstly forwomen “at risk” due to their age,
and then, with the arrival of screening techniques, to all pregnant women. Ultrasound scanning also
provides greater accuracy as to the term of the pregnancy, the number of embryos and to a certain
number of complications in childbirth. In certain cases, spotting apathologyduring theprenatal period
makes it possible to plan an early intervention and to orientatewomen to the appropriate department.
However, for the majority of suspected or diagnosed pathologies, no therapy is currently available,
raising the difﬁcult question of whether to continue with or terminate the pregnancy.
The ways in which prenatal diagnostic practices are regulated vary from country to country. Since
1975, France has distinguished between abortion due to “maternal distress” and abortion for medical
reasons, i.e. medical termination of pregnancy2 (MTP). The former is currently allowed up until the
12thweek of pregnancy; the second has no limits in time if the pregnancy is harming the mother’s
health or if “there is a strong probability that the unborn childwill have an ailment of particular gravity
recognised as being incurable at the time of the diagnosis”. Since 2001, the attestation of “particular
gravity” required to authorise a MTP must be provided by two doctors from a multidisciplinary PND
centre, after consulting the centre’s team which includes specialists from the various disciplines in
this ﬁeld.
Weneed to add another factor to this very general context of PNDpractices. The desire of legislators
to avoid any control,whichmight give the impression of State eugenics, led them to allowconsiderable
freedom of decision to couples, and even more so to doctors who, at the end of the day, were the ones
who have to make the ﬁnal decision. Yet inversely, a weak legal framework leaves jurisprudence with
an important role to play. The justice system has become an increasingly present actor and in France,
since 1980, we have seen a rise in the number of legal cases involving disabilities at birth, the most
emblematic being that of the Perruche case in 2000. These cases have affected medical practices,
especially in the ﬁeld of obstetric ultrasound. The increase in insurance premiums for professional
civil responsibility (which essentially affects self-employed doctors) has led numerous practitioners
to cease this aspect of their activity; the drop in the offering has contributed towards an increase in the
inequalities of access to PND (Moyse and Diederich, 2006, 2007). At the same time, the institution of
professional recommendations and accreditation procedures is tightening up the offering according
to quality criteria.
1.1. Routine screening for Down’s syndrome
In France, prenatal screening is available to all pregnant women. Regarding chromosomal anoma-
lies, ofwhichDown’s syndrome is by far themost frequent, a combination of differentmeasuresmakes
it possible to use a probabilistic calculation to objectivise the risk of the foetus being affected. Since
relatively recently, this screening is done during the ﬁrst trimester3 of the pregnancy, using a dose
of proteins in the mother’s blood stream (serum markers), ultrasound measurement of nuchal clarity
(thickness of the neck of the foetus) and other indicators, such as themother’s age. Above a certain risk
level (1/250), the diagnostic stage is systematically suggested. This involves taking a sample of amni-
otic ﬂuid or fragments of placenta with a view to examining the foetal karyotype4. Taking samples is
an invasive act, which can itself cause a miscarriage – a risk estimated at between 0.5 and 1%.
2 In France, it was only in 2001 that the term medical termination of pregnancy replaced that of therapeutic termination of
pregnancy, a term which referred solely to the legal indication of abortion until 1975, when the legislation was designed to
save the mother’s life.
3 Until very recently, the serummarker dosewasdoneduring the second trimester. Screeningduring theﬁrst trimester should
make it possible to eliminate a greater number of false positives (foetuses scanned as positive but which are ﬁnally shown to be
healthy) and thus, to perform fewer amniocentesis, thus limiting the risks, linked to this invasive act, of spontaneous abortions
of healthy foetuses.
4 Samples of placenta cells (trophoblast biopsy) can be taken early (between 11 and 14weeks of amenorrhea) whereas
amniocentesis is performed as from 15weeks. Cellular structure imposes a waiting period before full results can be obtained
(2–3weeks) but one method makes it possible to provide initial results for the most frequent anomalies within 48hours –
Down’s syndrome in particular. Whilst analysis of the karyotype targets Down’s syndrome, it also provides information on
other chromosomal anomalies.
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Imaging also plays an important role in screening for possible malformations. Three ultrasounds
are recommended and proposed throughout the pregnancy, at 12, 22 and 32weeks of amenorrhea
respectively, but on average, 4.5ultrasounds are in fact performed (enquête périnatale 20035). All of
these examinations are covered by social security.
At the endof thediagnostic stage,more often thannot, the risk is not conﬁrmed; thewomanand the
couple are thus reassured. One might nevertheless wonder about the long-term effects of the anguish
caused by announcing the risk. In the opposite situation, if the illness is incurable and considered to
be serious, the woman and/or the couple may request that the pregnancy be terminated due to foetal
anomaly.
According to Marc Dommergues6, approximately 100,000women in France, i.e. one in eight, are
currently identiﬁedeachyear as “beingat risk”ofhavingababywithananomaly, eitherdue toprevious
family history, or as a result of screening or of ultrasound signs. The vastmajority of them (almost 90%)
reach the diagnostic stage of analysing the foetal karyotype. Additional explorations, such asmagnetic
resonance imaging or scanner can also be proposed in order to achieve a more accurate diagnosis. In
France, there is no systematic search for genetic disorders, with three quarters of the prenatal tests
in molecular biology, which are carried out each year relating to previous family history. However,
given the progress made in imaging, it is not rare for ultrasound signs, which appear during normal
pregnancy monitoring to lead to suspicions of a genetic disorder. A quarter of genetic tests are thus
carried out following ultrasound signs and this number is likely to increase in the near future.
1.2. Prenatal diagnosis in ﬁgures
Congenital anomalies, taken all together, affect approximately 3% of pregnancies. In France, the
national frequency of medical terminations of pregnancy stands at 0.9%, i.e. about 7000 per year
(Agencede labiomédecine, 2008).Weﬁndvariationsat regional level,withnotably1.3%ofpregnancies
in the Paris region (Khoshnood et al., 2010).
There are several registers of congenital malformations in Europe, their data being combined in
the Eurocat database7. They all demonstrate a regular increase in the prevalence of MTP due to foetal
anomaly over the last 20years. In the Greater Paris region for example, between 1983 and 2005, the
proportion of diagnosed anomalies rose from 16 to 69% with the rate of MTP for these same anomalies
increasing from 9 to 35%.
Compared to other European countries, the level of MTP seems high. Indeed, whilst the combined
data from European registers of congenital anomalies show that, in 2006, 18% of pregnancies for
which an anomaly was diagnosed were terminated, this proportion stands at 33% for the two French
registers. In comparison, it stands at 9% for the two German registers, 10% for the Dutch register, 12%
for the Finnish register, 15% for the two Belgian registers taken together, 23% for the ﬁve registers
in the United Kingdom and the ﬁve registers in Italy and 38% for the three Spanish registers (Source
Eurocat).
2. Social sciences’ contribution to prenatal diagnosis
Whilst prenatal diagnostic practices are far from being new ground for social sciences and are the
subject of a great deal of literature, work has often remained focused on speciﬁc aspects8. They have
been more particularly examined in the ﬁelds of sociology and the history of science and techniques,
sociology of health and medical ethics, and in disability studies. The history of the spread of prenatal
5 http://www.sante.gouv.fr/htm/dossiers/perinat03/sommaire.htm.
6 Marc Dommergues is professor of obstetrics and gynaecology at hôpital de la Pitié-Salpétrière. This information comes from
the presentation he made at the “Disability and birth at stake” workshop on the 13thNovember2009, EHESS, Paris. For more
complete information on prenatal diagnosis, see Dommergues et al. (2003).
7 It should be noted that these are regional registers which are not representative of national populations.
http://www.eurocat-network.eu/prenatalscreeninganddiagnostic/prenataldetection rates.
8 The following brief review of existing literature is not intended in any way to be exhaustive.
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diagnostic techniques and the vital role played by doctors and researchers in the extension and gen-
eralisation of tools has been well documented for Britain (Farrant, 1985), France (Bourret and Huard,
1990; Isambert, 1980; Julian-Reynier and Bourret, 2006; Vassy, 2006a), various other European coun-
tries (Reid, 1991) and the USA (Press and Browner, 1997). There have also been numerous works on
the moral dilemmas facing women and practitioners, the anxiogenic nature of these practices and
the processes of deciding whether or not to accept a screening test or diagnosis, to continue or not
with the pregnancy (Garcia et al., 2008; Heyman and Henriksen, 2001; Katz-Rothman, 1987; Rapp,
2000; Van Berkel and van der Weele, 1999; Williams et al., 2002), the quality of the information pro-
vided on the tests and the risks of anomaly (Hunt et al., 2006; Marteau et al., 1992), the impossible
neutrality of doctors whose discourses often inﬂuence women’s choices, often at their own request
(Anderson, 1999; Weber et al., 2008; Williams et al., 2002). Regarding requests for authorisation to
terminate a pregnancy due to a foetal anomaly, studies show both the difﬁculties that professional
teams have in reaching a consensus when the issues go beyond simple medical factors and the dif-
ferent stances depending on specialisation (Dusart, 1995; Membrano, 2001). Some works condemn
the “overwhelming power” of the “new (biopolitical) monitoring system” which has resulted from
these medical practices, a system which is even more effective in that it has ceased to be authorita-
tive and coercive (Memmi, 2003). Disability studies have examined the impact of generalised PND on
the place of disabled persons in society. In particular, works mention the stronger negative attitudes
towards disabled people that these practices have produced and their implications in terms of dis-
crimination (Asch, 1999; Alderson, 2001; Saxton, 2000) and question the objectivity of an informed
choice (Kerr and Shakespeare, 2002; Shakespeare, 2006; see also Shakespeare, in this issue). Among
others, Moyse and Diederich (2001) foresee a weakening in the collective effort on behalf of disabled
persons, with theweight of dealingwith the disability falling back on the families due to their decision
to have brought a disabled child into the world. However, although the absence of disabled persons
in the debate on PND practices is criticised by disability studies, it is more often than not considered
to be additional proof of their exclusion and of the ever negative representations that are made of
them in all areas of social life, including those which concern them the most directly. In France, the
Perruche affair, which was so widely talked about at the start of the 2000s, was analysed not only
by jurists and sociologists, but also by psychoanalysts and philosophers, leading to the beginnings of
interdisciplinary thinking (Cayla and Thomas, 2002; Iacub, 2001).
To my knowledge, no study has ever analysed the historical modes of developing disability policies
and perinatal medicine, in order to shed light on how they were separated and why there is such little
exchange between the two worlds. Yet, several elements would appear to contribute towards this
state of events.
One such element is the State’s delegation to different actors: to private charities, on the one hand,
where disabled people have themselves played a vital role (Ville, 2010), and to clinicians and biologists
on the other. To these can be added the different paths taken by these same actors, linked on the one
hand to the strength of collective mobilisations and of the emergence of a health democracy, and on
the other hand, to the rapid growth in the technicisation of pregnancy and birth monitoring.
3. State delegation to different actors with different itineraries
3.1. Regarding disabled persons and public policies
Historically, themanagementofdisability inFrancewas left toprivate charities (Castel, 1981;Stiker,
2000). Itwasdisabledpersonsassociationsand theparentsofdisabledchildrenwhoensured treatment
and care in terms of rehabilitation for adults and specialist education for children, care which more
often than not meant the creation of specialist establishments. As from 1956, these establishments
were ﬁnanced by the French social security system’s “daily allowance”, with the State ratifying this
mode of disability management.
It has to be said that the ﬁrst disabled persons associations which came into being in the 1930s
were particularly dynamic and powerful, especially during the post-war period; they were able to
gain political support and their own representatives took part in ministerial work groups and played
an active role in the debates surrounding legislation that affected them (Barral, 2007). Later on, at
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the start of the 1960s, parents associations were organised to demand State aid to help care for those
who at that time were called the “congenitally disabled”. In particular, their efforts, combined with
those of paediatricians, child psychiatrists and physiotherapists, helped towards the creation of early
medicosocial action (Salbreux, 1995) which aimed to screen for impairments, as soon as babies were
born, in order to prevent or at least reduce any disabilities through early treatment and physiotherapy.
Doctors who were involved in treating disabilities (paediatricians, psychiatrists, physiotherapists),
of course very quickly, became the main actors in special needs education and rehabilitation. Indeed,
the recognition of medical rehabilitation practices –non-curative practices – became an important
challenge within the medical profession, leading to the creation of a new speciality (Frattini, 2010).
However, unlike what we are now seeing in perinatal treatment, they were never the sole actors in
the ﬁeld; on the contrary, they had to deal on a regular basis with actors in civil society, public policies
and social actions. The purpose of the interventions was access to education, jobs and ﬁnancial
independence, rehabilitation only being one means among others (of a social and political nature) of
achieving this.
With the mobilisation of disabled persons and the emergence of disability studies, the legitimacy
of rehabilitation medicine was damaged in the early 1980s. The individual medical approach, which
was designed to correct or compensate for impairments, to “normalise” people who were expected
to become as close to the norm as possible, was radically disputed. An alternative “social model”
for disability was put forward in an attempt to replace it, treating disability not as the result of an
impairment but as the result of cultural and environmental barriers (Oliver, 1990). Disability is not
caused by the impairment and by the functional limits it forces upon the person (medical model), but
by the obstacles to social participation in terms of accessibility, representation, discrimination, etc.
The disabled persons movement and disability studies made a certain number of demands relating to
the empowerment of disabled persons, the respect of their rights and their desire to be involved in
decisions that affected them, and valorised the positive aspects of the experience of disabled person
(Ville, 2005, 2008), thus contributing towards the deconstruction of stigmawhich, in certainmobilisa-
tions, went so far as to turn the stigma around and to assert their “disability pride”. These efforts were
not in vain, as disabled people played a large part in the international discussions on the deﬁnition
of disability which led to the International classiﬁcation of functioning, disability and health (WHO,
2001). They also helped to develop various conventions, recommendations and laws, both national
and international. Like many other countries, France changed its legislation. The terms of the French
Law dated 11th February2005 are a good reﬂection of these recent changes: “Law for the equal rights,
opportunities, participation and citizenship of disabled persons”. The accent thus shifted from the nor-
malisation of individuals towards an adaptation of the environment, making living in a community
accessible to all. The consequence of such a movement was to dilute the role of doctors, who became
just one group among numerous other social and political actors, not the least of whom were disabled
persons themselves, who had become the unavoidable experts of their own condition.
3.2. In the ﬁeld of perinatal medicine
Despite the relatively extensive media coverage that they received, the above changes did not
achieve the same level of penetration in all sections of society. The ﬁeld of perinatal medicine would
appear to have remained particularly impermeable. The result is that two radically different accepta-
tions of disability arenowatwork in the twoﬁelds. According to thenewconceptions,whilst children’s
disabilities before they have even been born can only be anticipated by taking into consideration their
immediate environment, representations of their families and, more generally, those of society and of
local modes of care, in perinatal medicine disability is generally seen as a simple equivalence of the
pathology which was diagnosed, and essentially remains a medical category.
The historical modalities of the constitution of the perinatal ﬁeld throw some light on these con-
ceptual differences. Doctors’ involvement in the ﬁeld of perinatality followed an opposite path to
that in the ﬁeld of disability policies. Indeed, the Protection maternelle et infantile9, created after the
9 System for the protection of mother and child, created in France in 1945.
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war, combined preventive medical measures and social monitoring measures involving non-medical
actors10. These measures contributed greatly to the drop in infant mortality. Attention then turned to
the period surrounding birth, perinatal mortality being particularly high in France in the 1960s to the
extent that some people were talking about “congenital peril” (Norvez, 1990). Measures were thus
concentrated on the technicisation of birth-related care and the monitoring of pregnancy. Initiative
was left to research and to medical actors, with the State, once a technical solution had been shown
to work, limiting its action to that of generalising its distribution and of playing a role in encouraging
and ensuring that it be implemented by society, until it became systematic (Norvez, 1990). This is the
model, which was constructed with the discovery of fetomaternal blood incompatibilities, the test
for which was made obligatory in 1962. Then followed, in the same vein, research on antibodies for
measles and toxoplasmosis. In the sameway, the generalisation of PNDwas initiated by an association
of biologists and doctors11 funded by the Caisse nationale d’assurance maladie12.
It would, therefore, appear that the shift of public health concerns from the period of childhood
to that of birth was accompanied by the effacing of social and political actors in favour of clinicians
–geneticians and biologists in particular – to whom over the last 40years the State has exclusively
delegatedmanagementof thepreventionof birthdisability, in France at least. It is uncertainwhether or
not this observation can be generalised. Particularly in Holland, the tradition regarding themonitoring
of pregnancy would appear to have been very different, as seen in the work carried out by Akrich and
Pasveer (1996).
Furthermore, whilst relatively independent of one another, a web of converging conditions
contributed towards making “therapeutic abortion” for foetal conditions an essential resource for
practitioners in this ﬁeld. Abortion as an indication due to a “serious and incurable” pathology of
the foetus is set in the French law of 1975, which decriminalises abortion. Before this law, therapeutic
abortionwas reserved for situationwhere the pregnancywas putting themother’s life in danger (Code
de la famille13, 1939). The question of extending this to the foetus was raised in the 1950s. The debate
began at the Académie de médecine14 upon the discovery of foetal malformations due to measles when
the diseasewas contracted by themother at the beginning of her pregnancy. A French studywas quick
to conﬁrmobservations,whichhadbeenmade in other countries: thesemalformations concerned95%
of caseswhere the disease occurred during the ﬁrst 7weeks of gestation (Lamy and Seror, 1956). Given
the frequency of the malformations, which, at the start of pregnancy were a virtual certainty, doctors
rapidly reached a consensus concerning the extension of therapeutic abortion. The door opened even
wider due to the number of resulting abortions was deemed to be negligible.
During the same period, as Jean-Paul Gaudillière explains elsewhere in this issue, themolecularisa-
tion ofmedicine and the resulting newapproaches to heredity, favoured the construction of hereditary
diseases as “errors of nature”which should be prevented rather than treated (Gaudillière, 2002). At the
same time, people were becoming aware of the harmful effects of “eugenetic”15 practices, particularly
in relation to the monitoring of pregnancy and when they interfered with natural selection. “Although
there have been huge beneﬁts from the gradual improvement in general and food hygiene conditions,
the ever-increasing possibilities of ﬁghting sterility, in utero mortality and neonatal mortality, these
beneﬁts go against natural selection, and we are right to expect greater survivability in the fragile eggs
and embryos which provide a large proportion of malformed newborn babies” (Turpin, 1954). And
whilst we cannot spot “errors of nature”, it is nevertheless possible to spot the excesses of medicine.
This argument was to last some time, being used until recently to justify life or death decisions in
neonatology (see introduction to this issue).
10 It is also in this type of conﬁguration that the centres d’action médicosociale précoce (centres for early medicosocial action)
came into being in 1976.
11 Association franc¸aise pour le dépistage et la prévention des handicaps de l’enfant (French association for the screening and
prevention of child disability).
12 French national health insurance fund.
13 French family code.
14 French academy of medicine.
15 The term eugenetics, whichwe owe to Adolphe Pinard, founder of paediatric nursing, who also defended eugenistic stances,
reﬂects the speciﬁcity of French eugenism, essentially medical, inseparable from hygienism (Carol, 1995).
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At the beginning of the 1970s, it was once again the argument of the low number of abortions
caused which persuaded the more conservative doctors to tolerate abortion following a positive
PND, as can be seen in this extract from a text by the Conseil national de l’ordre des médecins16.
After reasserting that “the respect for human life constitutes a fundamental dogma for a doctor’s
action and that embryonic life and foetal life can only be artiﬁcially separated from human life”
and after giving a reminder that the only authorised exception is when the mother’s life is in
danger, the text (which was unanimously voted) continues: “another exception of a completely
different nature, and which is not therapeutic, is also being envisaged. It is the termination of
pregnancy where there is an incurable embryopathy, which will lead to the birth of a child with
serious mental or physical anomalies. In the current state of science, this eventuality occurs very
rarely and one might imagine that in the future, new therapeutic solutions will make it possible
to give warning, on an increasingly frequent basis, of the occurrence of such accidents” (La Croix,
1970).
At that time, when the debate on decriminalisation of abortion was raging, and taking into account
the issues of a totally different nature which were also being discussed, the extension of therapeutic
abortion to include foetal conditions went almost unnoticed. It was taken for granted. Even though it
was infrequent, limited by the state of knowledge at that time, its practice (accepted by the scientiﬁc
and medical communities) existed before the law was introduced. It was sometimes based on known
risks, such as the one-in-two probability of having a haemophilic boy when the mother is carrying
the gene, leading to the male foetus being terminated. Sometimes the risks were not well-known,
such as when mothers were affected by toxoplasmosis and the number of aborted healthy foetuses
was not negligible (Daffos, 1995). With the development of the foetal karyotype in 1972, abortions
due to chromosomal anomaly could be performed on the basis of certainty, although this did not
remove the risk of losing a healthy child that went with the taking of samples. And whilst improved
techniques now allow us to make more accurate diagnosis in certain domains17, they also generate
new risks and new uncertainties.
The modalities behind the constitution of the two ﬁelds of intervention on disability thus took
two different paths. Regarding disability policies, the increasing number of actors and the involve-
ment of disabled persons themselves made it possible to co-construct a joint meaning of disability
deﬁned ﬁrst and foremost as a social issue. On this conceptual basis, it was possible to negotiate the
resources needed to reduce disability. Taking part in this, were numerous actors from civil society,
public authorities and many professions, including specialists in physical medicine and rehabilitation,
and disabled persons. Regarding perinatality, the focus on biological techniques, imaging and clinical
specialities such as genetics and obstetrics, led to a naturalistic conception of disability as an “acci-
dent” or “error” of nature which could be avoided, ﬁrstly through genetic counselling (which often
simply meant advising couples not to procreate), and then, through the extension of therapeutic abor-
tion to foetal indications, an extension which was virtually taken for granted as a resource deemed
even more acceptable in as much as it was rarely used –at least until the explosion of techniques
and the generalisation of their use in the middle of the 1980s. It was not until much later that the
issues raised regarding birth selection reached the public arena, via certain scientists and doctors who
saw it as a new form of eugenism (among others: Mattei, 2000; Nisand, 2001; Sicard, 2007; Testart,
1999). These diverging histories produced two immeasurable realities of disability and made it possi-
ble to have a better understanding of how hard it is to reconcile the two ﬁelds. It would, nevertheless,
appear that the current context, characterised on the one hand by disability studies opening up after
numerous internal debates (Shakespeare, 2006; Thomas, 2007) and, on the other hand by amovement
of increased reﬂexivity on the part of perinatality professionals with regard to their own practices,
is particularly encouraging with a view to initiating a very much needed debate between the two
ﬁelds.
16 National board of the French medical association.
17 In order to reﬂect the full complexity of PND situations, we should add that diagnostic certainties rarely have a prognostic
equivalent, the dominant rule being the diversity of clinical manifestations of diagnosed pathologies.
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